½ÃÀ庸°í¼­
»óǰÄÚµå
1392009

ÅëÁõ ÆÐÄ¡ ½ÃÀå : À¯Çüº°, ¿ëµµº°, ±â¼úº°, Á¦Çüº°, ó¹æÀüº°, ȯÀÚ ¿¬·Éº°, Á¢Âø Ư¼ºº°, ÀÛ¿ë ½Ã°£º°, ¾àÁ¦ Ŭ·¡½ºº°, À¯Åë ä³Îº°, Áö¿ªº°

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÅëÁõ ÆÐÄ¡ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 52¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 74¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö CAGR 5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø ÀÖ½À´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â ½ÃÀå ±Ô¸ð(2023³â) 52¾ï 9,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£ÀÇ CAGR 5.00% ½ÃÀå ±Ô¸ð ¿¹Ãø(2030³â) 74¾ï 5,000¸¸ ´Þ·¯
±×¸² 1. ¼¼°èÀÇ ÅëÁõ ÆÐÄ¡ ½ÃÀå Áö¿ªº° Á¡À¯À²(%)(2023³â)
Pain Patch Market-IMG1

ÅëÁõ ÆÐÄ¡´Â °æÇÇ ÆÐÄ¡·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç ±¹¼Ò ÅëÁõÀ» ¿ÏÈ­Çϱâ À§ÇØ ÇǺο¡¼­ Á÷Á¢ ¾à¹°À» Àü´ÞÇÏ´Â Á¢Âø ÆÐÄ¡ÀÔ´Ï´Ù. ÀÌ ÆÐÄ¡´Â Æí¸®ÇÏ°í »ç¿ëÇϱ⠽±°í Àå±â°£¿¡ °ÉÃÄ ¾à¹° ¹æÃâÀ» Á¦¾îÇÒ ¼ö ÀÖ½À´Ï´Ù. ÅëÁõ ÆÐÄ¡ ½ÃÀåÀº ¸¸¼º ÅëÁõ Àå¾ÖÀÇ À¯º´·ü Áõ°¡¿Í ´ëü ÅëÁõ °ü¸® ¿ä¹ýÀÇ Çʿ伺À¸·Î Áö³­ 10³â°£ Å« ¼ºÀåÀ» ÀÌ·ç¾ú½À´Ï´Ù. ÅëÁõ ÆÐÄ¡´Â °æÇÇ Ä¡·á ½Ã½ºÅÛÀ¸·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ÅëÁõÀ» ¿ÏÈ­½ÃŰ´Â ¾àÁ¦¸¦ ÇǺο¡¼­ Ç÷·ù¿¡ ¿Ã·Á ±¹¼Ò ÅëÁõÀ» ¿ÏÈ­½Ãŵ´Ï´Ù. °æ±¸ ¾à¹°¿¡ ºñÇØ ÅëÁõ ÆÐÄ¡ÀÇ ÀåÁ¡Àº ½ÅüÀÇ ¾à¹° ³óµµ¸¦ º¸´Ù ¾ÈÁ¤ÀûÀ¸·Î Á¶ÀýÇÒ ¼ö ÀÖ°í ÀϺΠ¾à¹°ÀÇ °æ±¸ »ýü ÀÌ¿ë·üÀ» ³·Ãß´Â °£¿¡¼­ÀÇ Ãʱ⠴ë»ç¸¦ ÇÇÇÒ ¼ö ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ¶ÇÇÑ »õ·Î¿î ¾à¹°Àü´Þ ±â¼úÀ» ÅëÇØ ÆÐÄ¡¿¡¼­ ¾à¹°À» Àå½Ã°£ ¹æÃâÇÒ ¼ö ÀÖ¾î 24½Ã°£ üÁ¦·Î È¿°úÀûÀÎ ÅëÁõ °ü¸®¸¦ ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÅëÁõ ÆÐÄ¡ ½ÃÀåÀº ÁÖ·Î °üÀý¿°, ¿äÅë, ½Å°æÀåÇØ¼º ÅëÁõ°ú °°Àº ¸¸¼º ÅëÁõ Áõ»óÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ßÀεǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ»ó¿¡´Â Àå±â ÅëÁõ °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇϸç ÅëÁõ ÆÐÄ¡´Â Æí¸®Çϰí È¿°úÀûÀÎ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ Áßµ¶°ú À§Àå ºÎÀÛ¿ë°ú °°Àº °æ±¸ ÁøÅëÁ¦¿Í °ü·ÃµÈ ÀáÀçÀû À§Çè¿¡ ´ëÇÑ ÀǽÄÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÅëÁõ ÆÐÄ¡¿Í °°Àº ºñħ½ÀÀû ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

±×·¯³ª ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÏ´Â ¿äÀεµ ÀÖ½À´Ï´Ù. ÀüÅëÀûÀÎ ÁøÅëÁ¦¿¡ ºñÇØ ÅëÁõ ÆÐÄ¡ ºñ¿ëÀÌ ³ô°í ÀϺΠÁö¿ª¿¡¼­´Â ÀÌ·¯ÇÑ Á¦Ç°¿¡ ´ëÇÑ »óȯÀÌ Á¦ÇÑµÇ¾î ½ÃÀå È®´ë¸¦ Á¦ÇÑ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÅëÁõ ÆÐÄ¡ÀÇ ½ÂÀο¡´Â ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀÌ ÀÖÀ¸¸ç, ÆÐÄ¡ »ç¿ë°ú °ü·ÃµÈ ÇǺΠÀÚ±Ø ¹× ¾Ë·¹¸£±â ¹ÝÀÀÀÇ À§ÇèÀÌ ½ÃÀå ¼ºÀåÀÇ ¾î·Á¿òÀÌ µÇ¾ú½À´Ï´Ù.

ÀÌ·¯ÇÑ ¹®Á¦¿¡µµ ºÒ±¸Çϰí ÅëÁõ ÆÐÄ¡ ½ÃÀå¿¡´Â ¸î °¡Áö ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ÅëÁõ ÆÐÄ¡¿¡¼­ ¹«¼± ¿¬°á ¹× ¼¾¼­ ÅëÇÕ µî ÷´Ü ±â¼úÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ±â¼ú Çõ½Å°ú Á¦Ç° Â÷º°È­ÀÇ ±æÀÌ ¿­¸®°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï ½ÃÀåÀÇ ¹Ì°³Ã´ °¡´É¼º°ú ¸ÂÃãÈ­ ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ±â¾÷ÀÌ ÇöÀçÀÇ Á¸À縦 È®´ëÇÏ°í ´Ù¾çÇÑ ¼ÒºñÀÚÃþ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ÅëÁõ ÆÐÄ¡ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀ嵿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀïÀü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ¹ÙÅÁÀ¸·Î ¼¼°è ÅëÁõ ÆÐÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ ÅëÁõ ÆÐÄ¡ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ÅëÁõ ÆÐÄ¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ ¹× ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • È¿°úÀûÀÎ ÁøÅë ¹× ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ÇǺÎÀÇ °ú¹ÎÁõ ¹× Àڱؼº
    • ¸ÂÃãÈ­ ÅëÁõ °ü¸®ÀÇ ÃâÇö
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÇÕº´ ¹× Àμö ½Ã³ª¸®¿À

Á¦4Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-Äڷγª ¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

  • ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø ¹× ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-À¯Çüº°(2018-2030³â)

  • ¿ÀÇÇ¿ÀÀ̵å ÅëÁõ ÆÐÄ¡
  • ºñ¿ÀÇÇ¿ÀÀ̵å ÅëÁõ ÆÐÄ¡

Á¦6Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-¿ëµµº°(2018-2030³â)

  • ¸¸¼º ÅëÁõ ÆÐÄ¡
  • ±Þ¼º ÅëÁõ ÆÐÄ¡

Á¦7Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-±â¼úº°(2018-2030³â)

  • ±âÁ¸ ¾à¹°Àü´Þ ÆÐÄ¡
  • ÷´Ü ¾à¹°Àü´Þ ÆÐÄ¡

Á¦8Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-Á¦Çüº°(2018-2030³â)

  • ´ÜÀÏ ¾àÁ¦ ÆÐÄ¡
  • º´¿ë ¿ä¹ý ÆÐÄ¡

Á¦9Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-ó¹æÀüº°(2018-2030³â)

  • ó¹æ ÅëÁõ ÆÐÄ¡
  • ½ÃÆÇ(OTC) ÅëÁõ ÆÐÄ¡

Á¦10Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-ȯÀÚ ¿¬·Éº°(2018-2030³â)

  • ¼ºÀοë ÅëÁõ ÆÐÄ¡
  • ¼Ò¾Æ¿ë ÅëÁõ ÆÐÄ¡

Á¦11Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-Á¢Âø Ư¼ºº°(2018-2030³â)

  • ÀúÀڱؼº ÆÐÄ¡
  • Ç¥ÁØ Á¢Âø ÆÐÄ¡

Á¦12Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-ÀÛ¿ë ±â°£º°(2018-2030³â)

  • ´Ü½Ã°£ ÀÛ¿ëÇü ÆÐÄ¡
  • ¿¬Àå ¸±¸®½º ÆÐÄ¡

Á¦13Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-¾à¹° Ŭ·¡½ºº°(2018-2030³â)

  • NSAID ÆÐÄ¡
  • ±¹¼Ò ¸¶Ãë ÆÐÄ¡
  • ±âŸ

Á¦14Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-À¯Åë ä³Îº°(2018-2030³â)

  • ¼Ò¸Å ¾à±¹
  • º´¿ø ¹× Áø·á¼Ò

Á¦15Àå ÅëÁõ ÆÐÄ¡ ½ÃÀå-Áö¿ªº°(2018-2030³â)

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • µ¶ÀÏ
  • ¿µ±¹
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • ASEAN
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«

Á¦16Àå °æÀï ±¸µµ

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

Á¦17Àå ºÎ¹®

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
AJY 23.12.20

The global pain patch market size was valued at US$ 5.29 billion in 2023 and is expected to reach US$ 7.45 billion by 2030, grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 5.29 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.00% 2030 Value Projection: US$ 7.45 Bn
Figure 1. Global Pain Patch Market Share (%), by Region, 2023
Pain Patch Market - IMG1

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period. The pain patches market has seen significant growth over the past decade driven by the increasing prevalence of chronic pain disorders and the need for alternative pain management therapies. Pain patches, also known as transdermal therapeutic systems, work by delivering pain relieving medications through the skin and into the bloodstream providing localized pain relief. The advantages of pain patches over oral medications include steadier control of drug levels in the body and avoidance of the first-pass liver metabolism which can reduce the oral bioavailability of some drugs. New advanced drug delivery technologies are also enabling prolonged and controlled release of medications from these patches for effective around-the-clock pain management.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

  • This report provides an in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

  • By Type
    • Opioid Pain Patches
    • Non-Opioid Pain Patches
  • By Application
    • Chronic Pain Patches
    • Acute Pain Patches
  • By Technology
    • Traditional Drug Delivery Patches
    • Advanced Drug Delivery Patches
  • By Formulation
    • Single Medication Patches
    • Combination Therapy Patches
  • By Prescription
    • Prescription Pain Patches
    • Over-the-Counter (OTC) Pain Patches
  • By Patient Age
    • Adult Pain Patches
    • Pediatric Pain Patches
  • By Adhesive Properties
    • Hypoallergenic Patches
    • Standard Adhesive Patches
  • By Duration of Action
    • Short-Acting Patches
    • Extended-Release Patches
  • By Drug Class
    • NSAID Patches
    • Local Anesthetic Patches
    • Other Medication Patches
  • By Distribution Channel
    • Retail Pharmacies
    • Hospitals and Clinics
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Key Players
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • Mylan N.V.
    • Endo Pharmaceuticals
    • Teikoku Pharma USA, Inc.
    • Acorda Therapeutics
    • Ibsa Institut Biochimique SA
    • Alembic Pharmaceuticals
    • Noven Pharmaceuticals, Inc.
    • Teva Pharmaceuticals
    • Strativa Pharmaceuticals
    • Galen Limited
    • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Type
    • Market Snippet , By Application
    • Market Snippet , By Technology
    • Market Snippet , By Formulation
    • Market Snippet , By Prescription
    • Market Snippet , By Patient Age
    • Market Snippet , By Adhesive Properties
    • Market Snippet , By Duration of Action
    • Market Snippet , By Drug Class
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for effective pain relief and non-invasive treatment
    • Skin Sensitivity and Irritation
    • Emergence of Personalized Pain Management
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pain Patch Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Non-Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Pain Patch Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Chronic Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Acute Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Pain Patch Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Traditional Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Advanced Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Pain Patch Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Single Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Combination Therapy Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Pain Patch Market, By Prescription, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Prescription Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Over-the-Counter (OTC) Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adult Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pediatric Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hypoallergenic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Standard Adhesive Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Short-Acting Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Extended-Release Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • NSAID Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Local Anesthetic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Other Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

15. Pain Patch Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa

16. Competitive Landscape

  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals
  • Analyst Views

17. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦